Characterization of the Adult Patient with Moderate to Severe Atopic Dermatitis (AD) in Dermatology Units of the hospital setting in Spain. DACAR STUDIO
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: LABORATORIOS LEO PHARMA, SA
- Execution start: 22/04/2021
- End of execution: 31/07/2021
- IP: JESUS TERCEDOR SANCHEZ